Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neuroproteomics in neurotrauma.

Andrew K Ottens1, Firas H Kobeissy, Erin C Golden

  • 1Center of Neuroproteomics and Biomarkers Research, McKnight Brain Institute, University of Florida, Gainesville, FL, USA. aottens@mbi.ufl.edu

Mass Spectrometry Reviews
|February 25, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inflammatory blood-based biomarkers to aid in the assessment and prognostication of traumatic brain injury: a TRACK-TBI study.

Journal of neuroinflammation·2026
Same author

Retraction: Comparing calpain- and caspase-3-mediated degradation patterns in traumatic brain injury by differential proteome analysis.

The Biochemical journal·2026
Same author

Retraction Note to: Degradation of βII-Spectrin Protein by Calpain-2 and Caspase-3 Under Neurotoxic and Traumatic Brain Injury Conditions.

Molecular neurobiology·2026
Same author

A consensus roadmap for post-traumatic epilepsy: Clinical biomarkers, research priorities, policy barriers, and pathways to interventional trials.

Epilepsia·2026
Same author

Orientia tsutsugamushi targets lamin A using Ank effectors and alters chromatin to inhibit NF-κB.

Communications biology·2026
Same author

Predicting intracranial hypertension as a secondary insult using the pathological peptidome of brain injured patients.

Scientific reports·2026

Neuroproteomics offers a new approach to study traumatic brain injury (TBI), a condition affecting millions. This review outlines methods for TBI biomarker discovery and understanding the brain

Area of Science:

  • Neuroscience
  • Proteomics
  • Biomarker Discovery

Background:

  • Traumatic brain injury (TBI) impacts more Americans annually than Alzheimer's and Parkinson's diseases combined.
  • The complex molecular mechanisms underlying TBI exacerbation remain under-investigated.
  • Few studies have utilized neuroproteomics to explore the molecular events following TBI.

Purpose of the Study:

  • To review the methodologies required for comprehensive neuroproteomics research in neurotrauma.
  • To establish a framework for large-scale protein analysis in TBI.
  • To facilitate immediate TBI biomarker discovery and advance systems biology understanding of brain trauma response.

Main Methods:

  • Discussion of sample types relevant for neurotrauma proteome analysis.

Related Experiment Videos

  • Overview of mass spectrometry techniques for protein identification and quantification.
  • Framework for applying neuroproteomics to TBI research.

    • Main Results:

    • Presents a systematic approach to neuroproteomics for studying TBI.
    • Highlights the potential for identifying TBI biomarkers.
    • Lays the groundwork for understanding the brain's response to trauma at a molecular level.

    Conclusions:

    • Neuroproteomics provides a powerful tool for advancing TBI research.
    • This approach can accelerate the discovery of diagnostic biomarkers for TBI.
    • Further insights from neuroproteomics may lead to novel therapeutic strategies for neurotrauma.